Breast Cancer

One survivor reflects on how quarantine amid the coronavirus outbreak is impacting her life and reflects on current events.

Making sense of a difficult situation feels like wading through quicksand. The more we struggle, the deeper we get. However, cancer survivors know how to face the fear of uncertainty even the uncertainty of the COVID-19 pandemic.

“Often you think we’re the victim, but there’s a lot that you can do to be your own advocate and participate in your healing,” says stage four metastatic breast cancer thriver Nalie Agustin.

While patients with cancer and survivors face extra risk due to the COVID-19 pandemic, they are more adept at handling the uncertainty and fear than one may think.

In the time of this pandemic, we're all in this together and need to give back where we can.

Genetic testing offers a care team a wealth of knowledge to help them craft treatments, but it also can help match patients to clinical trials for potentially better outcomes.

In the face of the COVID-19 pandemic patients with cancer who are considered to have weakened immune systems need to have a special emphasis placed on their care.

Patients faced with cancer are also faced with tough uphill financial battles, but there are assistance programs that can help.

Having the right understanding and information of a patient’s genetics can not only help treat cancer but also help prevent it.

Response minimizes exposure, frees up needed health capacity to deal with COVID-19.

Understanding a diagnosis is not just something for a patient's care team, the patient needs to understand their diagnosis as well.

Understanding biomarkers specific to breast cancer can guide treatment plans and help families with a history of the disease take preventive measures.

As CDK 4/6 inhibitors become a bigger part of the treatment of breast cancer, CURE® sat down with clinical nurse specialist Patricia Jakel to discuss the essentials about the drug.

A breast cancer diagnosis in women younger than 40 may result in disruptions in employment and job-related decisions, as well as a decrease in finances.

Health literacy is important for any patient with cancer trying to understand their diagnosis, and they need help from their care team to gain that.

Words are powerful and precious. And cancer survivors can use their stories and words of encouragement to help others as they go through their own journey with cancer.

Being a patient with cancer gives you a unique perspective that can become beneficial when serving as an advocate for others.

Women who consumed the highest level of dietary advanced glycation end products had a higher risk of breast cancer, particularly advanced stage disease, compared with those who consumed the lowest.

If patients take a deep breath and concentrate on the journey ahead after receiving a diagnosis, they can find a path forward, says one metastatic breast cancer thriver.

At the 37th Annual Miami Breast Cancer Conference, Dr. Valerie Lemaine discussed the signs and symptoms of BIA-ALCL, as well as how the disease is diagnosed and treated.

At the 2020 CURE® Educated Patient Breast Cancer Summit, oncology nurse Patricia Jakel had the chance to discuss the types of questions patients should be asking their care team.

At CURE’s Educated Patient Breast Cancer Summit, Stephanie Seban shared the ways a patient can become their own best advocate to thrive through their breast cancer journey.

Genetic and genomic testing is vital for patients with breast cancer and not only do patients need to understand why that is, but their physicians as well.

At the 37th Annual Miami Breast Cancer Conference Dr. Jean-Bernard Durand discussed data that showed how prescribed and personalized exercise programs can improve outcomes for patients with cancer who already face a high risk of cardiovascular disease.

“A person becomes a survivor from the point they are diagnosed and for the balance of their lives,” Dr. Don S. Dizon said in a presentation at the 37th Annual Miami Breast Cancer Conference®.

At the 37th Annual Miami Breast Cancer Conference, Dr. Kevin S. Hughes discussed genetic testing and what health care providers should be doing to identify more individuals at risk for cancer.

Xentuzumab in combination with Verzenio, with or without endocrine therapy, may be safe and effective in treating patients with solid tumors and advanced breast cancer.